ZA866250B - Purification and activation of proteins from insoluble inclusion bodies - Google Patents

Purification and activation of proteins from insoluble inclusion bodies

Info

Publication number
ZA866250B
ZA866250B ZA866250A ZA866250A ZA866250B ZA 866250 B ZA866250 B ZA 866250B ZA 866250 A ZA866250 A ZA 866250A ZA 866250 A ZA866250 A ZA 866250A ZA 866250 B ZA866250 B ZA 866250B
Authority
ZA
South Africa
Prior art keywords
protein
inclusion bodies
solution
purification
sds
Prior art date
Application number
ZA866250A
Other languages
English (en)
Inventor
Steven K Rausch
Original Assignee
Int Minerals & Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Minerals & Chem Corp filed Critical Int Minerals & Chem Corp
Publication of ZA866250B publication Critical patent/ZA866250B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA866250A 1985-08-19 1986-08-19 Purification and activation of proteins from insoluble inclusion bodies ZA866250B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/767,032 US4766224A (en) 1985-08-19 1985-08-19 Purification and activation of proteins from insoluble inclusion bodies

Publications (1)

Publication Number Publication Date
ZA866250B true ZA866250B (en) 1987-03-25

Family

ID=25078290

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA866250A ZA866250B (en) 1985-08-19 1986-08-19 Purification and activation of proteins from insoluble inclusion bodies

Country Status (13)

Country Link
US (1) US4766224A (de)
EP (1) EP0212960B1 (de)
AT (1) ATE91285T1 (de)
BR (1) BR8603944A (de)
CA (1) CA1267495C (de)
DE (1) DE3688663T2 (de)
DK (1) DK394786A (de)
ES (1) ES2000287A6 (de)
IE (1) IE61756B1 (de)
IL (1) IL79760A (de)
MX (1) MX168137B (de)
PT (1) PT83205B (de)
ZA (1) ZA866250B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8508340D0 (en) * 1985-03-29 1985-05-09 Creighton T E Production of protein
US4705848A (en) * 1986-06-02 1987-11-10 International Minerals & Chemical Corp. Isolation of bioactive, monomeric growth hormone
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
US5013653A (en) * 1987-03-20 1991-05-07 Creative Biomolecules, Inc. Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
CA1339757C (en) * 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
CA1305285C (en) * 1987-04-21 1992-07-14 Malcolm Roy Brandon Production of proteins in active forms
US5162507A (en) * 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
US4931543A (en) * 1987-05-11 1990-06-05 Cetus Corporation Process for recovering microbially produced interleukin-2
US4801691A (en) * 1987-05-15 1989-01-31 International Minerals & Chemical Corp. Method for removing sodium dodecyl sulfate from sodium dodecyl sulfate solubilized protein solutions
US6384194B1 (en) 1987-12-16 2002-05-07 Dsm N.V. Expression and purification of human interleukin-3 and muteins thereof
DE3880122D1 (de) * 1988-01-25 1993-05-13 Consortium Elektrochem Ind Verfahren zur solubilisierung von unloeslichem protein.
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
US5136027A (en) * 1989-05-02 1992-08-04 Abbott Laboratories Method for renaturing proteins in the presence of alkyl sulfate detergents
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
US4975529A (en) * 1989-08-18 1990-12-04 Monsanto Company Method of folding somatotropins
US5530100A (en) * 1990-05-07 1996-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Methods for purification of recombinantly produced proteins
US5023323A (en) * 1990-09-12 1991-06-11 Monsanto Company Method of somatotropin naturation
US5605691A (en) * 1992-09-17 1997-02-25 Ophidian Pharmaceuticals, Inc. Immunologically active proteins from inclusion bodies
EP0812358A1 (de) * 1995-02-24 1997-12-17 Cantab Pharmaceuticals Research Limited Polypeptide verwendbar als immunotherapeutischen mitteln und verfahren zur bereitung von polypeptiden
ATE358684T1 (de) * 1995-06-07 2007-04-15 Novartis Vaccines & Diagnostic Waessrige formulierung enthaltend tfpi und lösungsvermittlers
KR100374306B1 (ko) * 1995-07-14 2003-07-12 주식회사 엘지생명과학 재조합효모로부터과립구-콜로니자극인자를정제하는방법
ZA9711733B (en) 1996-12-31 1998-07-01 Monsanto Co Method for solubilization and naturation of somatotropins
DE69839553D1 (de) * 1997-01-08 2008-07-10 Invitrogen Corp Verfahren zur herstellung von proteinen
CA2294449A1 (en) * 1997-06-20 1998-12-30 New York University Electrospraying solutions of substances for mass fabrication of chips and libraries
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
WO2000002901A1 (en) * 1998-07-09 2000-01-20 University Technology Corporation High pressure refolding of protein aggregates and inclusion bodies
MXPA03003867A (es) * 2000-10-31 2004-10-15 Univ Colorado Regents Desagregacion mejorada de proteina y replegamiento utilizando alta presion.
WO2008042495A2 (en) 2006-07-21 2008-04-10 Life Technologies Corporation Sharply resolving labeled protein molecular weight standards
EP2059523A2 (de) * 2006-09-15 2009-05-20 Barofold, Inc. Hochdruckbehandlung von proteinen für reduzierte immunogenizität
CN102119168A (zh) * 2008-06-03 2011-07-06 帕特里有限公司 抗体纯化工艺
EP2475677B1 (de) * 2009-08-26 2018-08-01 Commonwealth Scientific and Industrial Research Organisation Verfahren zur herstellung einer seidendotierung
CN102977183B (zh) * 2012-12-11 2016-08-17 鲁南新时代生物技术有限公司 一种基因工程包涵体的洗涤方法
CN113773371B (zh) * 2021-09-16 2024-06-18 北京凯悦宁医药科技有限公司 一种vp1蛋白及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4426323A (en) * 1980-01-10 1984-01-17 Ionics, Incorporated Selected recovery of proteins from fermentation broths
US4462940A (en) * 1982-09-23 1984-07-31 Cetus Corporation Process for the recovery of human β-interferon-like polypeptides
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4599197A (en) * 1982-12-22 1986-07-08 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4518526A (en) * 1982-12-22 1985-05-21 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
IE56372B1 (en) * 1982-12-22 1991-07-03 Genentech Inc Microbially produced rennet methods for its production and plasmids used for its production
GR79124B (de) * 1982-12-22 1984-10-02 Genentech Inc
US4677196A (en) * 1985-09-06 1987-06-30 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies

Also Published As

Publication number Publication date
IL79760A0 (en) 1986-11-30
CA1267495A (en) 1990-04-03
US4766224A (en) 1988-08-23
DE3688663D1 (de) 1993-08-12
DK394786A (da) 1987-02-20
BR8603944A (pt) 1987-03-24
EP0212960B1 (de) 1993-07-07
IE862211L (en) 1987-02-19
PT83205B (pt) 1988-07-01
DK394786D0 (da) 1986-08-19
ATE91285T1 (de) 1993-07-15
EP0212960A2 (de) 1987-03-04
IL79760A (en) 1992-02-16
MX168137B (es) 1993-05-06
IE61756B1 (en) 1994-11-30
CA1267495C (en) 1990-04-03
EP0212960A3 (en) 1989-02-22
PT83205A (en) 1986-09-01
ES2000287A6 (es) 1988-02-01
DE3688663T2 (de) 1993-10-28

Similar Documents

Publication Publication Date Title
IL79760A0 (en) Purification and activation of proteins
DE3684078D1 (de) Reinigung und aktivierung von proteinen aus unloeslichen einschlusskoerpern.
IN162903B (de)
IL79972A (en) Protein recovery from inclusion bodies produced in transformant microorganisms
GB1401737A (en) Anti-coagulant isolation
ES2053537T3 (es) Aislamiento de la hormona de crecimiento biologicamente activa, monomera.
ATE113062T1 (de) Throminbindende substanz und verfahren zu ihrer herstellung.
GB1419929A (en) Method for the preparation of high purity kallikrein
IE38688B1 (en) Purification of orgotein
Rausch et al. Purification and activation of proteins from insoluble inclusion bodies.
EP0446850A3 (de) Verfahren zur Herstellung von rekombinantem Humaninterferon-beta in reiner Form
HUP9903078A2 (hu) Eljárás rekombináns, nem-lipidezett Osp-protein előállítására és tisztítására
KR910016926A (ko) 인간 β-인터페론의 정제방법
GB1440998A (en) Tuberculin active proteins and peptides